MJPS PHARMA CONSULTING LTD

Company Registration Number:
11558594 (England and Wales)

Unaudited micro entity accounts for the year ended 11 August 2025

Period of accounts

Start date: 01 October 2024

End date: 11 August 2025

MJPS PHARMA CONSULTING LTD

Contents of the Financial Statements

for the Period Ended 11 August 2025

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

MJPS PHARMA CONSULTING LTD

Company Information

for the Period Ended 11 August 2025




Registered office: 71-75
Shelton Street
London
Greater London
GBR
WC2H 9JQ
Company Registration Number: 11558594 (England and Wales)

MJPS PHARMA CONSULTING LTD

Balance sheet

As at 11 August 2025

10 months to
11 Aug 2025
£

2024
£
Current assets: 104,314 103,853
Net current assets (liabilities): 104,314 103,853
Total assets less current liabilities: 104,314 103,853
Total net assets (liabilities): 104,314 103,853
Capital and reserves: 104,314 103,853

MJPS PHARMA CONSULTING LTD

Balance sheet continued

For the year ending 11 August 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 12 August 2025
And Signed On Behalf Of The Board By:

Name: Peter John Sowood
Status: Director

The notes form part of these financial statements

MJPS PHARMA CONSULTING LTD

Footnotes to the Financial Statements

for the Period Ended 11 August 2025

  • 1. Employee Information

    Average number of employees: 0

MJPS PHARMA CONSULTING LTD

Footnotes to the Financial Statements

for the Period Ended 11 August 2025

  • 2. Off balance sheet disclosure

    No